62002CJ0041_EN
Parties
Grounds
Decision on costs
Operative part
Parties
In Case C-41/02,
ACTION under Article 226 EC for failure to fulfil obligations, brought on
13 February 2002
,
Commission of the European Communities,
represented by H. van Lier and H.M.H. Speyart, acting as Agents, with an address for service in Luxembourg,
applicant,
v
Kingdom of the Netherlands,
represented by H.G. Sevenster and S. Terstal, acting as Agents,
defendant,
THE COURT (Third Chamber),
composed of: A. Rosas, President of the Chamber, A. Borg Barthet, J.-P. Puissochet, J. Malenovský (Rapporteur) and U. Lõhmus, Judges,
Advocate General: M. Poiares Maduro,
Registrar: H. von Holstein, Deputy Registrar,
having regard to the written procedure and further to the hearing on
14 July 2004,
after hearing the Opinion of the Advocate General at the sitting on
14 September 2004,
gives the following
Judgment
Grounds
1. By its application, the Commission of the European Communities seeks a declaration from the Court that, first, by adopting and maintaining in force in its legislation Article 10(1) of the Warenwetbesluit Bereiding en behandeling van levensmiddelen (Decree implementing the Warenwet [Commodities Law], on the preparation and treatment of foodstuffs) of 10 December 1992 (Stb. 1992, 678) (‘the BBL Decree’), and subsequently Articles 2(1) and 5 of the Warenwetbesluit Toevoeging micro-voedingsstoffen aan levensmiddelen (Decree implementing the Warenwet, on the addition of micronutrients to foodstuffs) of 24 May 1996 (Stb. 1996, 311) (‘the TML Decree’), and secondly by applying a derogation scheme under which, where applicable, account is not taken of the substitutability of certain fortified food products, with the result that food products lawfully prepared and marketed in another Member State, fortified with vitamin A (in the form of retinoids), vitamin D, folic acid, selenium, copper or zinc, which are not substitution products or reconstituted products within the meaning of the TML Decree may not be marketed in the Netherlands unless that addition does not pose a risk for public health and meets an actual nutritional need, the Kingdom of the Netherlands has failed to fulfil its obligations under Articles 30 and 36 of the EC Treaty (now, after amendment, Articles 28 EC and 30 EC).
2. By order of the President of the Court of 30 July 2002, the Kingdom of Denmark was granted leave to intervene in support of the forms of order sought by the Kingdom of the Netherlands but, by letter received at the Court Registry on 21 July 2004, it advised that it would not intervene.
Legal framework
Community rules
3. It is common ground that, on the date relevant for this action, that is, at the end of the two-month period given in the supplementary reasoned opinion of 21 December 1998, referred to in paragraph 20 of this judgment, Community legislation did not contain any provisions governing the addition of nutrients such as vitamins and minerals to foodstuffs used for everyday consumption.
4. As regards foodstuffs intended for particular nutritional uses, some of them are governed by directives adopted by the Commission on the basis of Council Directive 89/398/EEC of 3 May 1989 on the approximation of the laws of the Member States relating to foodstuffs intended for particular nutritional uses (OJ 1989 L 186, p. 27).
National rules
5. The manufacture and the marketing of food products are governed in the Netherlands by the Wet van 28 december 1935 houdende voorschriften betreffende de hoedanigheid en aanduiding van waren (Law of 28 December 1935 on the classification and designation of goods, Stb. 1935, 793), in the version applicable at the relevant date for the present action (‘the Warenwet’).
6. Under Article 4(1) of the Warenwet, for the purpose of prohibiting goods which, in the course of normal use, may pose a risk for health or safety, the competent authority may, by administrative regulation, prohibit the preparation, manufacture, marketing or processing and use for purposes specified in that regulation of foodstuffs belonging to a category designated by that regulation which do not meet the requirements laid down by the regulation as to composition, manufacture, or qualities and properties.
7. Article 16(1) and (2) of the Warenwet provides:
‘1. The Minister may, in relation to goods belonging to a category designated in his decision, grant an exemption from the rules following from the application of any of Articles 4 to 15.
2. The Minister may also, in relation to goods belonging to a category designated in the corresponding decision, grant, on request, a derogation from those rules. …’
8. Article 10 of the BBL Decree provided, in its original version:
‘1. Foodstuffs shall not contain vitamins, fluoride or iodine compounds, amino acids or salts thereof, unless those substances are naturally present in them in the same composition and the same quantity.
2. Paragraph 1 shall not apply to foodstuffs covered by legal provisions providing otherwise.’
9. Paragraph 2 of that article has since been amended, with effect from 26 June 1996, by Article 10 of the TML Decree and now reads as follows:
‘Paragraph 1 shall not apply
(a) to fortified foodstuffs as referred to in [the TML Decree], as regards the presence of vitamins;
(b) to foodstuffs covered by legal provisions providing otherwise.’
10. Article 1(1)(a) to (d) of the TML Decree provides:
‘The following definitions shall apply for the purposes of the present Decree:
(a) micronutrients: nutrients which are indispensable for the functioning of the human organism which that organism cannot provide by itself and which must be consumed in small quantities;
(b) fortified foodstuffs: a foodstuff supplemented with one or more micronutrients, but the primary purpose of which is not to provide micronutrients;
(c) substitution product: a fortified foodstuff
– which is intended to replace an existing product and is as close as possible to it in appearance, consistency, taste, colour, smell and purpose; and
– to which one or more micronutrients have been added in proportions not exceeding those in which those substances are naturally present in the foodstuff to be replaced;
(d) reconstituted foodstuff: a fortified foodstuff
– prepared according to the directives relating to good production practices; and
– to which one or more micronutrients have been added up to proportions in which those substances were naturally present, before the preparation, in the edible part of the product or in the edible parts of the raw materials of the product but which were lost after or during preparation.’
11. Under Article 2(1) of the TML Decree, ‘the preparation or marketing of fortified foodstuffs which do not meet the requirements as to composition laid down in the present decree shall be prohibited’.
12. Article 5 of the same decree provides:
‘Micronutrients such as vitamin A in the form of retinoids, vitamin D, folic acid, selenium, copper and zinc shall be added to a fortified foodstuff solely for the purpose of making it a substitution product or a reconstituted foodstuff.’
13. Under Article 16(1) and (2) of the Warenwet, the Netherlands Minister for Health may grant an exemption or a derogation from the prohibition on marketing of a foodstuff under the TML Decree. Pursuant to Article 23 of the Warenwet, his decision may be subject to review by the College van Beroep voor het Bedrijfsleven.
14. In the case of foodstuffs fortified with micronutrients, the consistent policy of the Netherlands Minister for Health, endorsed by the College van Beroep voor het Bedrijfsleven, has been to grant a derogation only where two criteria are satisfied:
– the foodstuff to which micronutrients have been added must not per se be harmful to public health;
– the addition must meet an actual need, in particular nutritional.
Pre-litigation procedure
15. The Commission was informed that, in 1995 and 1996, two traders had been refused authorisation to market products in the Netherlands, whereas those products were already lawfully being marketed in other Member States: Kellogg’s for its breakfast cereals fortified with vitamin D and folic acid and Inkosport Nederland for its energy bars fortified with folic acid.
16. Considering those refusals to be contrary to Article 30 of the Treaty, the Commission, by two letters of formal notice of 26 June 1996, requested the Netherlands authorities to provide explanations on the matter.
17. Not satisfied with the replies it received from the aforementioned authorities, on 23 September 1997 the Commission issued two reasoned opinions to the Kingdom of the Netherlands. The Netherlands authorities replied to those opinions by letters of 12 and 18 December 1997.
18. Meanwhile, the draft decree and then the TML Decree were notified to the Commission pursuant to Council Directive 83/189/EEC of 28 March 1983 laying down a procedure for the provision of information in the field of technical standards and regulations (OJ 1983 L 109, p. 8), as amended by Directive 94/10/EC of the European Parliament and the Council of 23 March 1994 (OJ 1994 L 100, p. 30).
19. Following an exchange of letters, the Commission, considering that the scheme for derogating from the marketing prohibition went beyond what was necessary for health protection in that it required both that the addition of micronutrients not be harmful and that it meet an actual nutritional need, by letter of 22 December 1997 put the Netherlands authorities on formal notice to provide explanations on the infringement to which it referred.
20. Not satisfied with their response, it issued the Kingdom of the Netherlands with a reasoned opinion by letter of 31 August 1998, and sent a supplementary reasoned opinion by letter of 21 December 1998. The Netherlands authorities replied to those two opinions by letters of 8 September 1998 and 21 April 1999 respectively.
21. In those circumstances, the Commission decided to bring the present action.
The action
22. It is appropriate to note as a preliminary point that, notwithstanding the wording of the operative part of the application, the present action is not directed against the Netherlands rules. Indeed, the Commission states clearly that its action is not aimed at the marketing prohibition scheme established by the TML Decree as such. Likewise, it states that it is not raising the question of the formal compatibility with Community law of the procedure applicable to applications for derogation.
23. Thus, the Commission does not contest the obligation imposed on producers or importers of certain fortified foodstuffs to obtain a derogation from the prohibition on marketing those foodstuffs as laid down by the Netherlands rules. Its action is aimed solely at the practice, referred to in paragraph 14 of this judgment, which consists of the Netherlands authorities making the existence of an actual nutritional need a precondition for the granting of such a derogation. That is the subject-matter of the action as thus defined and on which the Court is asked to rule.
The national administrative practice
24. Since the Commission and the Netherlands Government do not agree on the features of the administrative practice in the Netherlands with regard to the granting of derogations from the prohibition on marketing certain fortified foodstuffs, it is appropriate, as a first step, to ascertain exactly what that practice comprises.
25. First of all, it is common ground that foodstuffs for everyday consumption which are fortified with vitamin A (in the form of retinoids), vitamin D, folic acid, selenium, copper or zinc may be marketed in the Netherlands, when they are not substitution products or reconstituted foodstuffs, only where a derogation has been granted from the marketing prohibition resulting from the combined provisions of Article 10 of the BBL Decree, as amended, and Articles 2(1) and (5) of the TML Decree.
26. It is also common ground that that derogation is granted by the Netherlands Ministry of Health only if, first, the foodstuff to which one of those nutrients has been added is not harmful to public health and, second, if the addition meets an actual nutritional need. Those two criteria are cumulative.
27. Contrary to the contentions of the Commission, the mere finding that a fortified foodstuff satisfies the first criterion is not sufficient to establish that the marketing of that product entails no risk for public health.
28. It is apparent from both the explanations of the Netherlands Government and the decisions taken by the competent national authorities on previous applications for derogations that the first criterion is met if the fortified foodstuff is not harmful per se, that is, if the quantity of the nutrient it contains is not dangerous in itself, regardless of which other sources of that nutrient there may be in the diet of the Netherlands population.
29. Vitamins and minerals are not as a general rule harmful in themselves but may have special harmful effects if taken to excess as part of the general nutrition, the composition of which cannot be foreseen or monitored (see, with respect to vitamins, Case 174/82 Sandoz
[1983] ECR 2445, paragraph 17; Case C-192/01 Commission
v Denmark
[2003] ECR I‑9693, paragraph 43; and Case C‑24/00 Commission
v France
[2004] ECR II‑0000, paragraph 50).
30. Accordingly, the mere fact that a foodstuff fortified with a given nutrient is not per se harmful to public health, and thus fulfils the first criterion, does not necessarily mean that it is free of risk. As pointed out by the Netherlands Government, it is still necessary to determine whether it entails a risk for public health having regard to other sources of that nutrient in overall food intake.
31. The Netherlands Government submits that that assessment must be carried out as part of the assessment for the second criterion, relating to the existence of an actual nutritional need.
32. Second, it is apparent from the derogation application procedures which have been dealt with by the competent Netherlands authorities that derogation is systematically refused when the fortified foodstuff does not satisfy the second criterion.
33. The example referred to by the Netherlands Government in order to demonstrate that a derogation may be granted in some cases for a fortified foodstuff which does not meet any nutritional need is not relevant. The example given relates to a marketing authorisation for margarine fortified with vitamin D, issued in 2002, that is, after the expiry of the time-limit given in the supplementary reasoned opinion of 21 December 1998. In addition, in that authorisation procedure, the competent Netherlands authorities found that there was a nutritional need for vitamin D among persons aged over 60 and that the marketing authorisation was to be subject to the condition that the margarine in question carry a label advising that the product should not be consumed by persons under 60 years of age.
34. Accordingly, the Commission is right to point to the systematic nature of the prohibition on marketing fortified foodstuffs which do not meet an actual nutritional need.
35. Lastly, it is apparent from the derogation application procedures which have been dealt with by the competent Netherlands authorities that, contrary to what the Commission maintains, it is for the Netherlands authorities to establish that there is no nutritional need in order to refuse a derogation application. Thus the decision of 10 March 1994 of the Netherlands Secretary for Welfare, Health and Culture taken in the ‘Punica’ case states that ‘as regards demonstrable need, the (Netherlands Health Ministry Claims) Commission finds that the appellant has not sufficiently demonstrated the existence thereof, but that the Ministry has plausibly shown that the addition is not necessary’.
36. Traders will, of course, attempt to show that their product meets such a need, but that does not mean that the burden of proof is reversed.
37. It is appropriate to consider whether the administrative practice in the Netherlands concerning the granting of derogations, as described above, constitutes a measure having effect equivalent to a quantitative restriction on imports and, if so, whether it may be justified on the basis of Article 36 of the Treaty, as the Netherlands Government maintains.
Whether there is a measure having effect equivalent to a quantitative restriction on imports
38. The free movement of goods between Member States is a fundamental principle of the Treaty, expressed in the prohibition laid down in Article 30 of the Treaty on quantitative restrictions on imports between Member States and all measures having equivalent effect.
39. The prohibition on measures having equivalent effect to restrictions set out in Article 30 of the Treaty covers all commercial rules enacted by the Member States which are capable of hindering, directly or indirectly, actually or potentially, intra-Community trade (see, in particular, Case 8/74 Dassonville
[1974] ECR 837, paragraph 5; Commission
v Denmark, paragraph 39; and Commission
v France, paragraph 22).
40. It is not disputed that the Netherlands administrative practice is a measure having effect equivalent to a quantitative restriction within the meaning of Article 30 of the Treaty.
41. Indeed, that practice, which requires that the marketing of foodstuffs fortified with vitamins and minerals and coming from other Member States where they are lawfully manufactured or marketed be subject to proof of a nutritional need in the Netherlands population, makes the marketing of such foodstuffs more difficult, if not impossible, and consequently hinders trade between the Member States (see, to that effect, Commission
v Denmark, paragraph 41).
The justification based on the protection of public health
42. As regards the question whether the Netherlands administrative practice may be justified on the basis of Article 36 of the Treaty, it is for the Member States, in the absence of harmonisation and to the extent that uncertainties continue to exist in the current state of scientific research, to decide on their intended level of protection of human health and life and on whether to require prior authorisation for the marketing of foodstuffs, always taking into account the requirements of the free movement of goods within the Community (see Sandoz, paragraph 16; Commission
v Denmark, paragraph 42; and Commission
v France, paragraph 49).
43. That discretion relating to the protection of public health is particularly wide where it is shown that uncertainties continue to exist in the current state of scientific research as to certain substances, such as vitamins, which, as observed in paragraph 29 of this judgment, are not as a general rule harmful in themselves but may have special harmful effects if taken to excess as part of the general nutrition, the composition of which cannot be foreseen or monitored (see Sandoz, paragraph 17; Commission
v Denmark, paragraph 43; and Commission
v France, paragraph 50).
44. Community law does not therefore preclude legislation of a Member State prohibiting in accordance with the precautionary principle, save for prior authorisation, the marketing of foodstuffs when nutrients other than those whose addition is lawful under that legislation have been added thereto (see, to that effect, Commission
v Denmark, paragraph 44; and Commission
v France, paragraph 51).
45. It is clear from Article 130r of the EC Treaty (now, after amendment, Article 174 EC) that the protection of human health is one of the objectives of the Community policy on the environment, that that policy aims at a high level of protection and is to be based inter alia on the precautionary principle, and that the requirements of that policy must be integrated into the definition and implementation of other Community policies. In addition, it follows from the case-law of the Court that the precautionary principle may also apply in policy on the protection of human health which, according to Article 129 of the EC Treaty (now, after amendment, Article 152 EC) likewise aims at a high level of protection (see, to that effect, Case C-157/96 National Farmers’ Union and Others
[1998] ECR I-2211, paragraphs 63 and 64; Case C-236/01 Monsanto Agricoltura Italia and Others
[2003] ECR I-8105, paragraphs 128 and 133; Commission
v Denmark, paragraph 49; and Commission
v France, paragraph 56; see also, to that effect, Case T-13/99 Pfizer Animal Health
v Council
[2002] ECR II-3305, paragraphs 139 and 140; Case T-70/99 Alpharma
v Council
[2002] ECR II-3495, paragraphs 152 and 153; and Case T-177/02 Malagutti-Vezinhet
v Commission [2004] ECR II‑0000, paragraph 54).
46. However, in exercising their discretion relating to the protection of public health, the Member States must comply with the principle of proportionality. The means which they choose must therefore be confined to what is actually necessary to ensure the safeguarding of public health; they must be proportional to the objective thus pursued, which could not have been attained by measures which are less restrictive of intra-Community trade (see Sandoz, paragraph 18; Commission
v Denmark, paragraph 45; and Commission
v France, paragraph 52).
47. Furthermore, since Article 36 of the Treaty provides for an exception, to be interpreted strictly, to the rule of free movement of goods within the Community, it is for the national authorities which invoke it to show in each case, in the light of national nutritional habits and in the light of the results of international scientific research, that their rules are necessary to give effective protection to the interests referred to in that provision and, in particular, that the marketing of the products in question poses a real risk for public health (see Commission
v Denmark, paragraph 46; and Commission
v France, paragraph 53).
48. A prohibition on the marketing of foodstuffs to which nutrients have been added must therefore be based on a detailed assessment of the risk alleged by the Member State invoking Article 36 of the Treaty (see Commission
v Denmark, paragraph 47; and Commission
v France, paragraph 54).
49. A decision to prohibit the marketing of a fortified foodstuff, which indeed constitutes the most restrictive obstacle to trade in products lawfully manufactured and marketed in other Member States, can be adopted only if the real risk for public health alleged appears sufficiently established on the basis of the latest scientific data available at the date of the adoption of such decision. In such a context, the object of the risk assessment to be carried out by the Member State is to appraise the degree of probability of harmful effects on human health from the addition of certain nutrients to foodstuffs and the seriousness of those potential effects (see Commission
v Denmark, paragraph 48; and Commission
v France, paragraph 55).
50. In assessing the risk in question, it is not only the particular effects of the marketing of an individual product containing a definite quantity of nutrients which are relevant. It could be appropriate to take into consideration the cumulative effect of the presence on the market of several sources, natural or artificial, of a particular nutrient and of the possible existence in the future of additional sources which can reasonably be foreseen (see Commission
v Denmark, paragraph 50).
51. In a number of cases, the assessment of those factors will demonstrate that there is much uncertainty, in science and in practice, in that regard. Such uncertainty, which is inseparable from the precautionary principle, affects the scope of the Member State’s discretion and thus also the manner in which the precautionary principle is applied.
52. It must therefore be accepted that a Member State may, in accordance with the precautionary principle, take protective measures without having to wait until the existence and gravity of those risks become fully apparent (see, to that effect, National Farmers’ Union, paragraph 63). However, the risk assessment cannot be based on purely hypothetical considerations (see Monsanto Agricoltura Italia, paragraph 106; Commission
v Denmark, paragraph 49; and Commission
v France, paragraph 56).
53. A proper application of the precautionary principle requires, in the first place, the identification of the potentially negative consequences for health of the proposed addition of nutrients, and, secondly, a comprehensive assessment of the risk for health based on the most reliable scientific data available and the most recent results of international research (see Commission
v Denmark, paragraph 51).
54. Where it proves to be impossible to determine with certainty the existence or extent of the alleged risk because of the insufficiency, inconclusiveness or imprecision of the results of studies conducted, but the likelihood of real harm to public health persists should the risk materialise, the precautionary principle justifies the adoption of restrictive measures (see Commission
v Denmark, paragraphs 52 and 53).
55. In the present case, the competent Netherlands authorities appear to examine separately, first, the specific effects of marketing an individual foodstuff containing a given quantity of nutrients, which they assess as part of the first criterion, and secondly the cumulative effect of the presence on the market of several sources, natural or artificial, of a nutrient, which they assess as part of the second criterion, relating to a nutritional need in the Netherlands population.
56. The Netherlands Government states that, for vitamin A (in the form of retinoids), vitamin D, folic acid, selenium, zinc and copper, the toxicological maximum, that is, the quantity above which the appearance of harmful effects may not be excluded, is not much higher than the recommended daily allowance, that is, the quantity which covers virtually all of the need for a given nutrient for all persons in good health in a particular population group, so that their addition to foodstuffs may be authorised only to a limited extent. For those ‘narrow safety margin’ nutrients, it is necessary to weigh the need to add them to foodstuffs against the risks that that entails and, where necessary and where justified by the risk assessment, apply restrictions to the marketing of products which do not meet a given nutritional objective.
57. However, even though it has been scientifically proven that the six nutrients at issue here carry a ‘narrow safety margin’, the recommended daily allowance of those nutrients is not the same as the toxicological maximum. In addition, as stated by the Advocate General in paragraph 42 of his Opinion, the slight difference between the recommended daily allowance and the quantity above which there is a health risk is not the same for each nutrient.
58. It follows that a foodstuff fortified with a given nutrient may not meet a nutritional need because the average food intake already provides the recommended daily allowance of that nutrient, although the marketing of that nutrient does not necessarily lead to intake over the toxicological maximum above which, according to current scientific knowledge, there is a real risk for public health.
59. In any event, the Netherlands Government has not produced any scientific studies showing that any intake over the recommended daily allowance of any of the six nutrients in question, regardless of by how much, entails a real risk for public health.
60. The Netherlands Government also submits that it is justified in refusing to allow the marketing of a fortified foodstuff which does not pursue any demonstrable nutritional objective, even when the ‘upper limit’ is not yet reached, in order to leave room for other products for which the nutritional need among certain groups among the population may be demonstrated.
61. In that connection, although the marketing of a fortified foodstuff intended for the entire population effectively reduces the difference between the quantity of nutrient present in the average food intake and the toxicological maximum, that in no way prevents the competent national authorities from subsequently authorising the marketing of other products fortified with the same nutrient intended only for groups in the population for whom the average food intake does not allow them to satisfy their need for that nutrient. Accordingly, the explanation given by the Netherlands Government cannot justify a practice of prohibiting a fortified foodstuff the consumption of which does not, even taking account of the overall food intake, attain the threshold above which there may be a real risk for public health.
62. Moreover, as rightly pointed out by the Commission, even after the national authorities have authorised the marketing of a foodstuff fortified with a given nutrient, they remain free to refuse a subsequent application for marketing authorisation on the basis of the situation brought about by the first authorisation (see, to that effect, the judgment of the EFTA Court of 5 April 2001 in Case E-3/00 EFTA Surveillance Authority
v Norway
[2000-2001] EFTA Court Report, p. 73, paragraphs 36 and 37).
63. In those circumstances, the systematic prohibition on the marketing of fortified foodstuffs, as it results from the administrative practice in the Netherlands, does not enable Community law to be observed in regard to the identification and assessment of a real risk for public health, which requires a detailed assessment, case by case, of the effects which the addition of the minerals and vitamins in question could entail (see, to that effect, Commission
v Denmark, paragraph 56).
64. Moreover, as rightly observed by the Commission, the case-file does not show that, in the derogation application procedures, the Netherlands authorities consider whether the foodstuff fortified with a given nutrient might be a substitute, in food intake, for traditional foodstuffs for which the addition of that nutrient is mandatory, nor even whether they take such a substitutive effect into account, where appropriate.
65. Thus, the Netherlands Government acknowledges that, in general, cereals may be a substitution product for slices of bread. Until 1 December 1999, the Netherlands rules required fat spreads to be fortified with vitamin D. However, the case-file does not show that, in the course of the appraisal of the application for authorisation to market cereals fortified with vitamin D, submitted by the trader Kellogg’s, the Netherlands authorities took that fact into account when they checked whether the marketing of those cereals would lead to an increase in the quantity of vitamin D in the average food intake of cereal consumers in relation to the quantity judged to be acceptable, and even necessary, in the average food intake of consumers of spreads.
66. The search for a possible substitutive effect must, however, be part and parcel of the in-depth study required by the case-law of the Court. Taking such an effect into account, where it exists, may lead to the conclusion that the marketing of a new fortified foodstuff will not lead to an increase in the quantity of nutrient in the average food intake, so that a derogation may be granted. Conversely, not taking that effect into account might shape food habits in a certain manner without any justification based on public health.
67. Accordingly, the Court finds that the Netherlands authorities have not complied with the requirements of Community law, particularly the requirement of an in-depth assessment, case by case, of the possible effects on public health of marketing foodstuffs fortified with any of the six nutrients in question.
68. Even though the cumulative effect of the presence on the market of a number of sources, natural or artificial, of a given nutrient and, therefore, the existence of a real risk for public health, are also examined by the Netherlands authorities as part of the criterion of nutritional need, the case-file nevertheless shows that, in fact, a marketing authorisation for a fortified foodstuff is granted only if it is also established that it is necessary to enable the Netherlands population to cover its needs for vitamins or minerals (see the decision of the Netherlands Secretary for Welfare, Health and Culture taken in the ‘Punica’ case, cited in paragraph 35 of this judgment). This latter approach is not part of the assessment of risk for public health, however.
69. Although the criterion of nutritional need of the population of a Member State can play a role in its detailed assessment of the risk which the addition of nutrients to foodstuffs may pose for public health, the absence of such a need cannot, by itself, justify a total prohibition, on the basis of Article 36 of the Treaty, of the marketing of foodstuffs lawfully manufactured and/or marketed in other Member States (see Commission
v Denmark, paragraph 54; and Commission
v France, paragraphs 59 and 60).
70. It follows from all of the foregoing considerations that, by applying an administrative practice under which foodstuffs for everyday consumption fortified with vitamin A (in the form of retinoids), vitamin D, folic acid, selenium, copper or zinc which are lawfully produced or marketed in other Member States may be marketed in the Netherlands, when they are neither substitution products nor reconstituted foodstuffs within the meaning of Article 1(1)(c) and (d) of the TML Decree, only if that enrichment meets a nutritional need in the Netherlands population and, in addition, without ascertaining whether those fortified foodstuffs might be a substitute for foodstuffs already marketed for which the addition of those nutrients is mandatory, the Kingdom of the Netherlands has failed to fulfil its obligations under Article 30 of the Treaty.
Decision on costs
Costs
71. Under Article 69(2) of the Rules of Procedure, the unsuccessful party is to be ordered to pay the costs if they have been applied for in the successful party’s pleadings. Since the Commission has applied for costs and the Kingdom of the Netherlands has been unsuccessful, the latter must be ordered to pay the costs.
Operative part
On those grounds, the Court (Third Chamber) hereby:
1. Declares that, by applying an administrative practice under which foodstuffs for everyday consumption fortified with vitamin A (in the form of retinoids), vitamin D, folic acid, selenium, copper or zinc which are lawfully produced or marketed in other Member States may be marketed in the Netherlands, when they are neither substitution products nor reconstituted foodstuffs within the meaning of Article 1(1)(c) and (d) of the Warenwetbesluit Toevoeging micro-voedingsstoffen aan levensmiddelen (Decree implementing the Warenwet, on the addition of micronutrients to foodstuffs) of 24 May 1996 only if that enrichment meets a nutritional need in the Netherlands population and, in addition, without ascertaining whether those fortified foodstuffs might be a substitute for foodstuffs already marketed for which the addition of those nutrients is mandatory, the Kingdom of the Netherlands has failed to fulfil its obligations under Article 30 of the EC Treaty (now, after amendment, Article 28 EC);
2. Orders the Kingdom of the Netherlands to pay the costs.